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Abstract
Background: Utilities and disability weights (DWs) are metrics used for calculating Quality-Adjusted Life Years and
Disability-Adjusted Life Years (DALYs), respectively. Utilities can be obtained with multi-attribute instruments such as
the EuroQol 5 dimensions questionnaire (EQ-5D). In 2010 and 2013, Salomon et al. proposed a set of DWs for 220
and 183 health states, respectively. The objective of this study is to develop an approach for mapping EQ-5D
utilities to existing GBD 2010 and GBD 2013 DWs, allowing to predict new GBD 2010/2013 DWs based on EQ-5D
utilities.
Methods: We conducted two pilot studies including respectively four and twenty-seven health states selected from
the 220 DWs of the GBD 2010 study. In the first study, each participant evaluated four health conditions using the
standard written EQ-5D-5 L questionnaire. In the second study, each participant evaluated four health conditions
randomly selected among the twenty-seven health states using a previously developed web-based EQ-5D-5 L
questionnaire. The EQ-5D responses were translated into utilities using the model developed by Cleemput et al. A
loess regression allowed to map EQ-5D utilities to logit transformed DWs.
Results: Overall, 81 and 393 respondents completed the first and the second survey, respectively. In the first study,
a monotonic relationship between derived utilities and predicted GBD 2010/2013 DWs was observed, but not in
the second study. There were some important differences in ranking of health states based on utilities versus GBD
2010/2013 DWs. The participants of the current study attributed a relatively higher severity level to musculoskeletal
disorders such as ‘Amputation of both legs’ and a relatively lower severity level to non-functional disorders such as
‘Headache migraine’ compared to the participants of the GBD 2010/2013 studies.
Conclusion: This study suggests the possibility to translate any utility derived from EQ-5D scores into a DW, but
also highlights important caveats. We observed a satisfactory result of this methodology when utilities were derived
from a population of public health students, a written questionnaire and a small number of health states in the
presence of a study leader. However the results were unsatisfactory when utilities were derived from a sample of
the general population, using a web-based questionnaire. We recommend to repeat the study in a larger and more
diverse sample to obtain a more representative distribution of educational level and age.
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Background
Disability weights (DWs) and utilities (also known as
index values, preference weights or QALY weights) are
common metrics allowing a quantitative evaluation of
health states related to diseases, injuries or risk factors.
They reflect the preference of individuals for a certain
health state and quantify the severity of health loss asso-
ciated with a certain health state. They are also crucial
components in health economic evaluations and in dis-
ease burden assessments.
Disease burden assessments using the Disability-
Adjusted Life Year (DALY) metric play an increasingly
important role in public health research. The disability
weight (DW) is a crucial component in the DALY
formula, as it allows combining morbidity and mortality
[1–4, 5, 6]. The DW expresses the relative reduction in
Health-Related Quality of Life (HRQoL), on a scale from
zero (perfect health) to one (worst possible health state).
By weighing the years lived with disease, these years are
“translated” into fully lost life years. Indeed, living
10 years with a 10% reduction in HRQoL (i.e., DW =
0.10) would be equal to losing one full year of good
health (e.g., by dying one year before the life expect-
ancy). As a result, both morbidity and mortality are
expressed in the same currency, namely the number of
healthy life years lost. Initially, DWs were elicited from
participants who did not necessarily suffer from the
studied health state, using time trade-off or person
trade-off methods. However other valuation techniques
for eliciting DWs exist [7]. Ideally DWs should be devel-
oped from international studies hence ensuring internal
comparability. However, several health states are not in-
cluded in such international initiatives. Therefore resort-
ing to specific elicitation studies is the only option. For
instance, to estimate the YLDs of stage 0 (in situ) melan-
oma in Belgium during the two first month of treatment,
Tromme et al. multiplied the number of patients with
stage 0 melanoma in Belgium for the 2009–2011 period,
i.e. 1772 patients by the derived DW for the two first
month of treatment, i.e. 0.3345 and by the duration, i.e.
2 months [8] but the DWs obtained in these standalone
studies are not comparable to an international set of dis-
ability weights.
As part of the Global Burden of Disease 2010 Study
(GBD 2010), Salomon et al. proposed a wide set of DWs
based on paired comparison questions for 220 health
states in which respondents considered two health out-
comes which were described briefly in lay language [1].
An update of these DWs was generated for the Global
Burden of Disease 2013 Study (GBD 2013) by incorpor-
ating results of new surveys in four European countries
(Hungary, Italy, the Netherlands, and Sweden). The two
studies combined resulted in a set of DWs based on
60,890 participants [2, 3].
In health economic evaluations, health “utilities” are a
crucial component of Quality-Adjusted Life Years
(QALYs). A utility of 0 means that a health state is
equivalent to death, whereas a utility of 1 means full
health. These values can be derived using multi-attribute
instruments such as the EuroQol 5 dimensions question-
naire (EQ-5D) [9]. The EQ-5D includes five dimensions
(mobility, self-care, usual activities, pain/discomfort and
anxiety/depression) and five severity levels in each di-
mension (EQ-5D-5 L). This self-completion question-
naire was developed by the EuroQol group and is
applicable to a wide range of patient’s health states.
To derive utilities, individuals are asked to score their
health state using EQ5D questionnaire. Their scores
may then be converted to a utility using a set of regres-
sion coefficients (or tariffs). These tariffs are obtained
using direct valuations of a subset of health states from
the general public using visual analog scale or trade-off
methods and are available for certain countries. Some
countries have integrated EQ-5D in their national
health surveys, resulting in population average utilities
that can be used as an indicator of general population
health [10–14].
Many studies calculated utilities using EQ-5D for a
wide range of diseases such as cancer [8], cardiovascular
diseases [15] or diabetes [16]. EQ-5D has also been ap-
plied in the context of DALY-based disease burden stud-
ies. In these instances, the EQ-5D utilities had to be
“translated” to DWs. So far, authors have assumed the
DW to be equal to one minus the utility, or equal to the
age and sex specific population average utility minus the
elicited utility [8, 17]. However, these approaches do not
guarantee comparability with the GBD 2010/2013 DWs.
Mapping is a better strategy to predict DWs from util-
ities when DWs are not available for burden estimations
[18]. The objective of this study was to propose an ap-
proach for mapping EQ-5D utilities to existing GBD
2010 and GBD 2013 DWs, and to predict “new” GBD
2010/2013 DWs based on EQ-5D utilities, i.e., for health
states currently not included in the GBD studies.
Methods
Study design and participants
First pilot study
Four health states representing the spread of the
GBD 2010/2013 DW distribution were selected
(Table 2). In other words, we selected four health
states which values shared the GBD 2010/2013 DW
distribution in three equal parts. Native speakers
translated existing health state descriptions developed
by Salomon et al. [1] into French and back-translated
them into English (Additional file 1). A written version of
the EQ-5D-5 L questionnaire excluding the visual
analogue scale part was used and three different versions
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of the questionnaire were designed. As recommended by
Euroquol group, we used the five level EQ-5D question-
naire (EQ-5D-5 L) because the measurement properties of
EQ-5D-5 L are superior to the EQ-5D-3 L in terms of
feasibility, ceiling effects, discriminatory power and con-
vergent validity [9].
Each version was composed of the same set of health
states but with a different order of questioning, to ex-
plore possible order effects. The first version presented
health states in increasing order of GBD 2010/2013
health state severity, the second version in decreasing
order of GBD 2010/2013 health state severity, and the
third one did not present health states in a certain order
of severity.
The questionnaire consisted of two main parts. The
first part was the same in each of the three versions of
the questionnaire and included questions about age, sex
and marital status. The second part included evaluation
of four health states. Participants were asked to imagine
being in a certain health state described by the lay de-
scriptions developed by Salomon el al. [3], but without
knowing the name of the health state. They would then
select the most appropriate level of functioning for each
of the five dimensions: mobility, self-care, usual activ-
ities, pain/discomfort and anxiety/depression. The re-
spondents were students of the Public Health faculty at
the Université catholique de Louvain (UCL), Brussels,
Belgium, and were recruited during two courses in June
2014. There was no time limitation to answer the ques-
tionnaire and the study leader was present during the
study allowing participants to ask any question.
Second pilot study
Twenty-seven health states representing the spread of
the GBD 2010/2013 DW distribution were selected
(Table 2). Native speakers with knowledge of the topic at
hand, translated existing health state descriptions devel-
oped by Salomon et al. [1] into French and then back-
translated them into English (Additional file 1). Dutch
translation of the thirty-two health states came for the
Haagsma et al. study [2]. A web-based version of the
EQ-5D questionnaire excluding the visual analogue scale
part, was developed using the Qualtrics software. As for
the first study, the first part of the questionnaire in-
cluded socio-demographics questions, with additional
questions on disease/injury experience (yes/no answers),
income and educational level. Income categories were
derived from Haagsma et al. [2]. The second part in-
cluded evaluation of four health states. As in the first
pilot study, participants were asked to imagine being in
a certain health state described by the lay descriptions of
Salomon et al. but without knowing the name of the
health state [1]. Eight versions of the second part were
developed. Each version included evaluation of four
health states representing the spread of the GBD 2010/
2013 DW distribution. The questionnaire was assigned
to participants through a computer algorithm that at-
tributed the questionnaire version with the lowest per-
centage of participants at the time of assignment.
Participants had to answer all questions to validate their
participation. The respondents were recruited by email
among students of the Public Health faculty at the UCL
and among principals of Brussels’s primary and second-
ary schools and using a social network through general
and private messages on Facebook. Snowball sampling
[19] was used for the recruitment strategy, i.e., existing
study participants were asked to recruit future subjects
among their contacts. The data were collected in June
2015. A reminder was sent three weeks after sending the
first email to the students of UCL and the principals of
Brussels’s schools. Through Facebook, a first request was
published on the Facebook public wall of the two main
leaders of the study on June 1 2015. Then, three recalls
were sent through private messages to all friends of the
two main leaders of the study on June 3, 16 and 22,
2015.
Data analysis
Two steps recommended by the EQ-5D-5 L user guide
were followed to transform the EQ-5D-5 L scores re-
ported by each participant into a utility [9]. A function
previously developed by the EuroQoL group was used to
translate the scores from a 5 L to a 3 L scale, because no
Belgian tariffs exist for the 5 L version. The EQ-5D-3 L
results were then converted to utilities using the tariff
model developed by Cleemput et al. for the Belgian
population [10].
Statistical analysis
For all EQ-5D utilities, overall means, medians, standard
deviation and ranges were calculated. Utilities in this
study were compared with GBD 2010 and GBD 2013
DWs using Spearman correlation coefficients. We used
sample paired t-tests to test whether there was a differ-
ence of mean utilities between the pilot studies and the
corresponding GBD 2010/2013 DWs.
A locally weighted scatterplot smoothing (loess) re-
gression model was run between the utilities and the
logit transformed corresponding GBD 2010/2013 DWs
[1, 3]. We arbitrarily chose an anchor point that when
DWs equated to 1, utility equated 0 and when DWs
equated 0, utility equated 1. Logit transformed DWs
were then predicted for each of the utility scores from
the loess fit. To retransform the scale and obtain DW
values that range from 0 to 1, an inverse logistic trans-
formation was applied to these predicted values.
Analyses were done with R version 3.0.2 and JMP pro
12. R code and developed mapping functions are
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available through: https://github.com/brechtdv/eq5d-
mapping.
Results
First pilot study
In total 81 students completed the first survey, 57 were
female (70.4%) and 57 had never been married (70.4%).
They were on average 29.6 years old (SD 8.4) (Table 1).
Average utilities ranged from 0.667 (SD 0.131) for
“Fractures, treated (long term)” to 0.289 (SD 0.203) for
“Schizophrenia: acute state” (Table 2).
One participant attributed a negative utility (i.e., worse
than death) to ‘schizophrenia, acute’ (−0.158) and three
participants attributed a utility of one (i.e., perfect
health) to ‘severe wasting’.
There was a monotonic relationship between derived
utilities and predicted GBD 2010/2013 DWs, i.e., the
lower the utility, the higher the predicted GBD DW
(Fig. 1).
There was a negative correlation between utilities and
GBD 2010 DWs (rho = −1, p =0.083) and GBD 2013
DWs (rho = −1, p = 0.083).
There was a significant difference between the com-
plement of the utilities (1 – utility) and GBD 2010 DWs
(p = 0.085) and between the complement of the utilities
and GBD 2013 DWs (p = 0.099).
‘Fractures treated, long term’ was ranked first, i.e.
with the lowest disability weight as in the GBD 2010
study (but ranked third in the GBD 2013 study) and
‘Schizophrenia, acute’ was ranked last, i.e. with the
highest disability weight as in the GBD 2010/2013
studies (Table 3).
Second pilot study
393 respondents completed the second survey. The aver-
age age was 36.4 years (SD 12.5) and 26.3% of the re-
spondents were male. 2.5% were younger than 20, 36%
were between 20 and 29 years old, 26% were between 30
and 39 years old and only 4% were older than 60. The
majority of the respondents were highly educated, i.e.
39.7% had a bachelor’s and 46.6% had a master’s degree.
Most of the respondents had a medium income level, i.e.
54.8% had a household annual income ranging from
25,000 to 52,000 euros (~27,000 US$ - 56,500 US$). Of
all respondents, 30.8% already experienced a disease or
injury experience in the past and 44.3% had never been
married (Table 1).
The median of the utility distribution of the 27
health states was 0.455 (range: 0.106 - 0.826). The
median of the selected 27 GBD 2010 DWs was 0.114
(range: 0.003 – 0.756). The median of the 27 GBD
2013 DW was 0.117 (range: 0.003 – 0.778). According
to the utilities, the top three less severe health states
Table 1 Description of the study population N (%) - Mean (SD)
Study 1 (n = 81) Study 2 (n = 393)
N (%) N (%)
Age (years) – Mean (SD) 29.6 (8.4) 36.4 (12.5)
Male 57 (70.4) 104 (26.5)
Marital status Married 16 (20) 153 (38.9)
Divorced 7 (8.8) 28 (7.1)
Widower 0 (0.0) 5 (1.3)
Separated 0 (0.0) 33 (8.4)
Never been married 57 (71.3) 174 (44.3)
Income level (in €) <25 000 70 (17.8)
25 – 44 000 84 (21.4)
45 – 52 000 98 (33.4)
>52 000 57 (14.5)
Not available 84 (21.4)
Educational level Primary 1 (0.3)
Lower secondary 8 (2.0)
Higher secondary 37 (9.4)
Bachelor 156 (39.7)
Master or higher 183 (46.6)
Not available 2 (0.5)
Disease experience status Yes 121 (30.8)
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in pilot study 2 were ‘Distance vision, mild’, 0.826 (SD
0.154), ‘Anemia, mild’, 0.813 (SD 0.138) and ‘Asthma,
controlled’,0.809 (SD 0.128). ‘Fracture of pelvis short
term’, 0.106 (SD 0.203), ‘Multiple sclerosis’, 0.144 (SD
0.198) and ‘Gout, acute’, 0.193 (SD 0.212) were the
top three more severe health states (Table 2 & 3,
Fig. 2). Most of the utilities were between 0.5 and
0.6, and corresponded to the health states with a
moderate severity level.
Overall 64 of the participants (16%) in the second pilot
study, attributed negative utilities to at least one health
state. We obtained negative utilities for 11 health states
(41%) among the 27 health states included in the second
pilot study (Fig. 2). In health states including negative
values, the most common were ‘Fracture of pelvis short
term’ (22%), ‘Traumatic brain injury (long-term conse-
quences)’ (20%) and ‘Multiple sclerosis (severe)’ (20%).
Conversely, 64 participants (16%) attributed a utility of 1
to at least one health state. The top three most common
health states with a utility of 1 were ‘Distance vision,
mild’ (25%), ‘Anemia, mild’ (22%) and ‘Asthma, con-
trolled’ (16%).
The Spearman rank correlation coefficient between
the utilities derived from pilot study 2 and the GBD
2010 DWs equaled −0.808 (p < 0.001). There was a sig-
nificant difference between the complement of the util-
ities (1 – utility) and GBD 2010 DWs (p < 0.001). The
differences between the complement of the utilities and
the GBD 2010 DWs ranged from −0.097 (‘Schizophrenia,
acute’) to 0.645 (‘Amputation of both legs (long-term with
Table 2 Utilities by studies
ID Health states Mean Utility
study 1
SD Utility
study 1
Mean Utility
study 2
SD Utility
study 2
DW2010 DW2013
1 Fractures, treated (long term) 0.667 0.131 0.694 0.130 0.003 0.005
2 Distance vision, mild 0.826 0.154 0.004 0.003
5 Anemia, mild 0.813 0.138 0.005 0.004
8 Amputation of toe 0.650 0.127 0.008 0.006
11 Asthma, controlled 0.809 0.128 0.009 0.015
22 Claudication 0.644 0.177 0.016 0.014
29 Stroke, long term mild 0.550 0.168 0.021 0.019
37 Disfigurement, level 1 with itch or pain 0.639 0.177 0.029 0.027
47 Fracture of foot bones (long term,
without treatment)
0.615 0.151 0.033 0.026
55 Headache tension type 0.530 0.169 0.350 0.204 0.040 0.037
60 Amputation of both legs (long-term
with treatment)
0.304 0.244 0.051 0.088
77 Injured nerves (short term) 0.553 0.193 0.065 0.100
96 Fracture tibia, patella (short term) 0.389 0.170 0.087 0.050
107 Musculoskeletal problems
(arms moderate)
0.474 0.173 0.114 0.117
111 Severe wasting 0.474 0.204 0.486 0.263 0.127 0.128
149 Crohn’s disease 0.455 0.200 0.225 0.231
155 Parkinson’s disease moderate 0.391 0.201 0.263 0.267
161 Gout, acute 0.193 0.212 0.293 0.295
174 Severe chest injury (short term, with
or without treatment)
0.331 0.201 0.352 0.369
186 Fracture of pelvis short term 0.106 0.203 0.390 0.279
193 Headache (migraine) 0.548 0.194 0.433 0.441
200 Rectovaginal fistula 0.449 0.217 0.492 0.501
203 Terminal phase, without medication
(for cancers, end-stage kidney/liver disease)
0.317 0.225 0.519 0.569
206 AIDS cases (not received ARV treatment) 0.360 0.228 0.547 0.582
214 Traumatic brain injury (long-term consequences) 0.200 0.257 0.625 0.637
219 Multiple sclerosis (severe) 0.144 0.198 0.707 0.719
220 Schizophrenia, acute 0.289 0.203 0.341 0.192 0.756 0.778
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treatment’). The average difference between 1-utilities and
the GBD 2010 DWs was 0.30 (SD 0.18). The three highest
observed differences between 1-utilities and the GBD
2010 DWs were ‘Amputation of both legs (long-term with
treatment)’ (0.645), ‘Headache tension type’ (0.610) and
‘Fracture tibia, patella (short term)’ (0.524). The three low-
est observed differences were noticed for ‘Headache (mi-
graine)’ (0.019), ‘Rectovaginal fistula’ (0.059) and ‘AIDS
cases not received ARV treatment)’ (0.093) (Fig. 3).
The Spearman rank correlation coefficient between
the derived utilities from pilot study 2 and the GBD
2013 equaled −0.801 (p < 0.001). There was a significant
difference between the complement of the utilities (1 –
utility) and the GBD 2013 DWs (p < 0.001). The differ-
ences ranged from −0.112 (‘Schizophrenia, acute’) and
0.613 (‘Headache tension type’). The average difference
between 1-utilities and the GBD 2013 DWs was 0.30
(SD 0.19). The three highest observed differences be-
tween 1-utilities and DWs GBD 2013 were for ‘Fracture
of pelvis short term’ (0.615), ‘Headache tension type’
(0.613) and ‘Amputation of both legs (long-term with
treatment)’ (0.608). The three lowest differences ‘Head-
ache (migraine)’ (0.011), ‘Rectovaginal fistula’ (0.05) and
AIDS cases (not received ARV treatment)’ (0.06).
The relationship between the utilities and predicted
DWs for both GBD 2010 and 2013 studies was not
monotonic (Fig. 3), meaning that both utilities and pre-
dicted DWs do not increase/decrease concurrently, and
there were major differences in the ranking of health
states between the second pilot study and the GBD 2010
and 2013 studies (Table 3). Most of the differences were
located in the middle of the distribution, i.e. for health
states that were located around the median of the
distribution. ‘Amputation of both legs’ was ranked 11th
and 12th in the GBD 2010/2013 studies and fell to the
23rd place in this study. ‘Headache tension type’ was
ranked 10th in the GBD 2010/2013 studies and 19th in
this study. On the other hand, participants of GBD
2010/2013 studies judged more severe ‘Headache mi-
graine’ and ‘Rectovaginal fistula’ which held respectively
the 21st and 22nd compared to pilot study 2 where they
held the 11th and 15th rank.
Pilot study 1 versus pilot study 2
We also observed some differences of mean utility
between study 1 and study 2. The differences ranged
from −0.05 for ‘Schizophrenia, acute’ to 0.180 for ‘Head-
ache tension type’ and we found higher agreement with
health states located at the ends of the distribution, i.e.
‘Fractures, treated’ and ‘Schizophrenia’.
For ‘Severe wasting’, most of the participants of the
second pilot study assigned a score of three (i.e., moder-
ate) to all five EQ5D dimensions. Participants of the sec-
ond pilot study evaluated that ‘Severe wasting’ caused
more frequently none/moderate (Level 1 & 3) problems
for mobility (Dimension 1), no problem of autonomy
(D2) and weak (Level 2) pain/discomfort (D4). Partici-
pants of the first pilot study evaluated more frequently
that ‘Severe wasting’ caused weak (Level 2) problems of
mobility (D1), weak (Level 2) problem of autonomy (D2)
and none (Level 1) pain/discomfort (D4).
For ‘Headache tension’ the participants of the second
study attributed a higher level for three of the five
EuroQol dimensions than participants of the first study.
Participants of the second study evaluated more fre-
quently that ‘Headache tension’ caused severe pain/
Fig. 1 Mapping utilities developed in pilot study 1 vs GBD 2010 DWs and GBD 2013 DWs. Grey dots = individual utility value , red dots = mean
utility, grey line = linear regression line, black line = loess regression line
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Table 3 Ranking of the health states by studies
Red = higher than study-specific median for GBD 2010–2013 studies and lower than study-specific median for study 2
Green = lower than study-specific median for GBD 2010 - GBD 2013 studies and higher than study-specific median for study 2
Yellow = equal to study-specific median
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discomfort (Level 4 – D4), severe problems to accomplish
daily activities (Level 4 – D3) and moderate anxiety/de-
pression (Level 3 – D5). Participants of the first study
evaluated more frequently that ‘Headache tension’ caused
moderate pain/discomfort (Level 3 – D4), moderate
problems to accomplish daily activities (Level 3 – D3) and
weak anxiety/depression (Level 2 – D5) (Table 4).
Overall, in the first pilot study the scores for mobility
(D1) and autonomy (D2) dimensions were in average
higher than in the second pilot study. In the second pilot
Fig. 2 Distribution of utilities derived in pilot study 2. Medians and ranges of the 27 utilities. Black dots represent outliers. Health state IDs are
available in Table 2.
Fig. 3 Mapping utilities developed in pilot study 2 versus GBD 2010 DWs and GBD 2013 DWs. Grey dots = individual utility value,
red dots = mean utility, grey line = linear regression line, black line = loess regression line
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study, the scores for activities (D3), pain/discomfort
(D4) and anxiety/depression (D5) dimensions were in
average higher than in the first pilot study (Table 4).
Discussion
DALY-based burden of disease studies play an increas-
ingly important role in public health research [20]. As
the required DWs for the health states under study may
not be available, flexible and practical ways of eliciting
DWs that are comparable with existing GBD DWs are
therefore needed. We proposed a mapping approach
based on a loess regression model to easily predict any
GBD 2010/2013 DW from EQ-5D5L utilities. To our
knowledge, the current study is the first to map EQ-5D
utilities to GBD 2010/2013 DWs.
Recently, Burstein et al. used loess regression to map
SF-12 utilities to GBD 2010 DWs [21]. They showed a
weaker rank order correlation (−0.7) between GBD 2010
DWs and SF-12 scores than we found between DWs
and utilities (> − 0.8). They also found that the relation-
ship between GBD 2010 DWs and SF-12 scores was
non-monotonic. The mapping function developed by
Burstein et al. was less satisfactory than in the first pilot
study but better than in the second pilot study. Burstein
Table 4 Dimensions and levels frequency by study
D1: Mobility D2: Autonomy D3: Daily activities D4: Pain/discomfort D5: Anxiety/ depression
Study 1 Study 2 Study 1 Study 2 Study 1 Study 2 Study 1 Study 2 Study 1 Study 2
ID = 1 Fractures, treated (long term)
Level 1: None 25% 39% 63% 63% 37% 37% 5% 5% 69% 67%
Level 2: Weak 62% 44% 31% 31% 49% 49% 78% 78% 28% 28%
Level 3: Moderate 11% 17% 6% 6% 12% 12% 15% 15% 1% 6%
Level 4: Severe 2% 0% 0% 0% 1% 1% 1% 1% 1% 0%
Level 5: Extreme/Impossible 0% 0% 0% 0% 0% 0% 1% 1% 0% 0%
Mean 1.91 1.78 1.43 1.33 1.78 1.61 2.16 2.19 1.35 1.39
SD 0.67 0.72 0.61 0.48 0.71 0.73 0.58 0.52 0.57 0.60
ID = 55 Headache tension type
Level 1: None 52% 30% 53% 48% 6% 2% 1% 0% 19% 16%
Level 2: Weak 37% 24% 30% 14% 32% 10% 12% 6% 47% 18%
Level 3: Moderate 10% 18% 14% 30% 51% 34% 56% 20% 28% 34%
Level 4: Severe 1% 22% 4% 4% 9% 44% 25% 60% 6% 24%
Level 5: Extreme/Impossible 0% 6% 0% 4% 2% 10% 6% 14% 0% 8%
Mean 1.60 2.50 1.68 2.02 2.69 3.50 3.22 3.82 2.22 2.90
SD 0.72 1.30 0.85 1.15 0.82 0.89 0.79 0.75 0.82 1.18
ID = 111 Severe Wasting
Level 1: None 14% 28% 26% 42% 6% 25% 46% 23% 11% 19%
Level 2: Weak 32% 17% 35% 26% 17% 17% 30% 43% 20% 23%
Level 3: Moderate 27% 28% 27% 23% 43% 26% 20% 28% 37% 30%
Level 4: Severe 27% 19% 12% 6% 30% 25% 5% 6% 27% 23%
Level 5: Extreme/Impossible 0% 8% 0% 4% 4% 8% 0% 0% 5% 6%
Mean 2.68 2.60 2.26 2.04 3.07 2.74 1.84 2.17 2.95 2.74
SD 1.02 1.11 0.98 0.88 0.93 1.10 0.91 0.68 1.06 0.99
ID = 220 Schizophrenia
Level 1: None 56% 73% 31% 73% 2% 13% 43% 38% 2% 4%
Level 2: Weak 16% 8% 22% 10% 7% 6% 22% 21% 1% 4%
Level 3: Moderate 19% 10% 35% 12% 17% 17% 15% 13% 10% 10%
Level 4: Severe 9% 8% 11% 6% 52% 42% 16% 19% 28% 25%
Level 5 : Extreme/Impossible 1% 2% 1% 0% 21% 21% 4% 8% 58% 58%
Mean 1.84 1.58 2.30 1.50 3.81 3.52 2.15 2.37 4.38 4.29
SD 1.09 1.07 1.07 0.92 0.94 1.28 1.25 1.37 0.90 1.05
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et al. selected 62 health states, collected data from a
sample of 3791 respondents and corrected for outliers.
Except that participants were enrolled in Seattle and
during two GBD workshops, no information was avail-
able on age, educational or income level and disease ex-
perience status of their study population.
We observed major differences in the validity of the
mapping function between both pilot studies, which
could be influenced by the different study populations
and questionnaire forms. Indeed, a higher prediction
quality was observed when we derived utilities from a
written version of the EQ-5D questionnaire compared to
a web-based questionnaire. One explanation could be
that during the first study, which included the written
version of the EQ-5D questionnaire, one of the study
leaders was present to answer the questions of the par-
ticipants. This may have increased the understanding of
the health state definitions. The wider standard devia-
tions of the second pilot study underscore this hypoth-
esis. Even though we used the updated version of the lay
definitions developed by Salomon et al. [3], we still ob-
served that descriptions were not straightforward to
understand for lay population. In the second pilot study,
we observed a weaker quality of the prediction for more
severe disorders, for example ‘Schizophrenia, acute’, ‘Epi-
lepsy severe’ or ‘Rectovaginal fistula’.
In addition, we observed some overlap between the
health state descriptions developed by Salomon et al. [3]
and the five dimensions included in the EQ-5D ques-
tionnaire that could have influenced the health state
valuations. For example, the definition of ‘Fracture of
pelvis: short term’ was, “…You have severe pain, and
cannot walk or do daily activities” which provided infor-
mation on the level of mobility, self-care, usual activities
and pain/discomfort dimensions included in the EQ-
5D5L questionnaire. We observed that utilities for health
states with overlap in descriptions had lower variation.
For example, in the second pilot study the lowest stand-
ard deviation was observed for ‘Amputation of toe’ (SD
0.127) and ‘Asthma, controlled’ (SD 0.128), both of them
included information on pain and daily activities in their
descriptions.
We also observed that there were some important dif-
ferences of ranking between GBD 2010/2013 DWs and
utilities derived in the second utilities study. Respon-
dents of our study ranked amputation of both legs lower
(more severe) and acute schizophrenia higher (less se-
vere) than the respondents of the GBD 2010/2013 stud-
ies. In addition to the overlap between the health state
descriptions described above, one explanation could be
that for participants included in the pilot studies it was
more difficult to imagine and evaluate functional limita-
tions (D1 – D3) for psychiatric disabilities than for im-
paired mobility.
Several limitations may also have influenced the final
results.
In the second pilot study, a sample of 27 GBD 2010
health states was used, and each health state was evalu-
ated at least 30 times. Chuang et al. determined that
each health state has to be at least evaluated 100 times
to be representative of the population of responses [22].
We indeed observed better results in the first study,
where each health state was at least evaluated 81 times.
The study population was not representative of the
Belgian population. The first study population (n = 81)
was composed of students in public health, mostly fe-
male and young adults. In the second study (n = 393),
and despite the snowball strategy, most of the partici-
pants were between 20 and 39 years (72%), were highly
educated. The web-based questionnaire as well as the
age of two main coordinators of the study could be an
explanation of the study population characteristics.
Hopefully, Haagsma et al. demonstrated no significant
effects of educational level on DWs for injury conse-
quences in the Dutch population [17]. However other
studies, which also used EQ-5D questionnaire, demon-
strated that participants aged 18–59 evaluated health
states less severely than those aged 60 and over and that
older participants attributed less weight to morbidities
and pain experience than younger [23, 24].
In addition, some authors reported that the judgment
of people who are in a certain health state and health
professionals differ significantly from judgment of
healthy people [15]. Thirty-one percent of the respon-
dents included in the second study had a disease experi-
ence and mostly were expert in public health, which
might have influenced the results. Utilities could have
been under or over estimated. However we do not rec-
ommend to restrict participants to healthy individuals
because we believe that utilities have to represent the
average ‘preference’ of health of the studied population.
We chose to include negative values of individual util-
ity in the Cleemput’s model, indicating some health
states to be worse than death for some participants. We
obtained a negative value for one (25%) health state in
the first pilot study and for 11 health states (41%) in the
second pilot study. For a study including a larger popu-
lation, it is recommended to constrain values between 0
and 1 to improve the prediction model [25] but in the
practice, the issues raised by the negative values for EQ-
5D health states are complex [26]. In addition, to per-
form the final mapping we arbitrarily chose that when
DWs equated to 1, utility equated 0, indicating that it
exists health state worse than death. This is one of the
methodological and philosophical choice difference be-
tween the utilities derived from EQ-5D tool and DWs
derived from pairwise comparison that could impact the
predictions. This is also why assuming the DW to be
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equal to one minus the utility do not guarantee compar-
ability with the GBD 2010/2013 DWs.
In addition, both ‘short’ and ‘long’ term health states
were included in the study and the time framing was not
explicitly defined. Some studies demonstrated that the
duration of a health state has an impact on the health
state valuations and that poor states of health became
more intolerable the longer they last [17, 18, 23, 27].
However Salomon et al. showed that the framing of
paired comparsion questions in terms of temporary or
chronic outcomes in a pairwise comparison did not
affect the valuation of the health states [3].
Finally, there are fundamental differences between the
pairwise comparison (PC) and EQ-5D techniques.
First, GBD PC was anchored to Population Health
Equivalence answers, while EQ5D Flemish tariffs [10]
was anchored to Visual Analogue Scale. Although there
are systematic differences between those methods, both
are indirect and should not affect the mapping. Second,
EQ5D questionnaire was designed to assess Quality of
Life (QoL) of patients, with a given scenario of health
states but DWs were designed to quantify the severity of
a single health state. In other words, utilities are patient
specific, whereas DWs are health state specific. In this
study, we deviate from this original definition by defin-
ing health state specific utilities. Both methods also do
not evaluate health states on the same dimensions of
health [28]. With EQ-5D instrument participants have to
evaluate health states on five dimensions of health, each
of them including five levels of severity and with pair-
wise comparison, two health states are presented to
healthy people and they have to decide which they
regarded as being healthier based on their own judgment
and experience. These fundamental differences of meth-
odology can also explain the differences we observed be-
tween GBD 2010/2013 DWs and utilities.
Conclusion
This study suggests the possibility to translate any utility
derived from EQ-5D scores into a DW, but also high-
lights important caveats. We observed a satisfactory re-
sult of this methodology when utilities were derived
from a population of public health students, a written
questionnaire and a small number of health states in the
presence of a study leader. The results were however un-
satisfactory when utilities were derived from a sample of
the general population, using a web-based questionnaire.
For the sake of validating the study, we recommend re-
peating the first study (i.e. using a printed version of the
questionnaire coupled with an available support of the
study leader and a small number of health states to
evaluate) in a larger and more diverse sample to obtain a
more representative distribution across educational
levels and ages because DWs may vary between and
within countries potentially impacting the mapping be-
tween utilities and GBD 2010/2013 DWs. Recommenda-
tions on future study designs in regards of an optimal
sample size are not straightforward to provide, since
knowledge on the variability of data in such studies is
lacking. Moreover according to Brazier et al., the sample
size (number of people giving responses) used in other
mapping studies is very broad as it ranged from 68 to
23,647 [29]. We think that further studies using simula-
tion process, could help to answer the sample size. How-
ever at least as important as the sample size, is the
representativeness of the sample for the population at
hand. To avoid selection basis a probability sample (e.g.
random sample) of the participants is required.
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